应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CNMD CONMED Corporation
交易中 08-17 14:49:09 EDT
49.01
-1.40
-2.78%
最高
49.93
最低
48.96
成交量
14.35万
今开
49.56
昨收
50.41
日振幅
1.92%
总市值
14.68亿
流通市值
14.63亿
总股本
2,995万
成交额
707.42万
换手率
0.48%
流通股本
2,986万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
CONMED Corporation 宣布FDA批准的Airseal®机器人解决方案扩展适应症,适用于Intuitive Da Vinci 5六角套管
美股速递 · 07-22
CONMED Corporation 宣布FDA批准的Airseal®机器人解决方案扩展适应症,适用于Intuitive Da Vinci 5六角套管
财报前瞻|CONMED Corporation本季度营收预计小幅下滑,机构观点偏谨慎
财报Agent · 07-22
财报前瞻|CONMED Corporation本季度营收预计小幅下滑,机构观点偏谨慎
CONMED公司宣布:John E. Gallagher接任Todd Garner成为新任首席财务官;Garner将留任顾问至2026年11月2日
美股速递 · 06-18
CONMED公司宣布:John E. Gallagher接任Todd Garner成为新任首席财务官;Garner将留任顾问至2026年11月2日
CONMED公司签订协议 将于6月3日回购2027年到期的2.25%可转换优先票据 - 美国证券交易委员会文件
美股速递 · 06-04
CONMED公司签订协议 将于6月3日回购2027年到期的2.25%可转换优先票据 - 美国证券交易委员会文件
CONMED Corporation于2026年5月27日提交SEC文件:签署首份综合修订协议并提高信贷额度激活通知
美股速递 · 06-01
CONMED Corporation于2026年5月27日提交SEC文件:签署首份综合修订协议并提高信贷额度激活通知
南微医学收购Conmed三大产品线 内窥镜耗材版图再扩张
美股速递 · 03-18
南微医学收购Conmed三大产品线 内窥镜耗材版图再扩张
加载更多
公司概况
公司名称:
CONMED Corporation
所属市场:
NYSE
上市日期:
--
主营业务:
CONMED Corporation于1970年根据纽约州法律成立,2020年5月成为特拉华州公司。CONMED是一家以用于微创手术和监测的外科手术器械和设备为重点的医疗技术公司。公司的产品主要被外科医生和各个专科包括骨科,普通外科,妇产科,神经外科,肠胃科的主治医师所使用。公司的主要目标就是通过创新医疗设备的开发,对现有产品的改进以及新技术的开发,以此来提高手术结果的质量和病人的护理,并且能降低风险,创伤,费用以及手术的时间。公司相信,通过满足这些目标,可以提高其预测的能力,适应客户的需求和市场机遇,并且能为股东带来丰厚的投资回报。
发行价格:
--
{"stockData":{"symbol":"CNMD","market":"US","secType":"STK","nameCN":"CONMED Corporation","latestPrice":49.01,"timestamp":1786992547807,"preClose":50.41,"halted":0,"volume":143458,"delay":0,"changeRate":-0.027772267407260437,"floatShares":29860800,"shares":29951248,"eps":1.841012,"marketStatus":"交易中","change":-1.4,"latestTime":"08-17 14:49:09 EDT","open":49.555,"high":49.93,"low":48.96,"amount":7074199.891794,"amplitude":0.019242,"askPrice":49.09,"askSize":122,"bidPrice":48.93,"bidSize":42,"shortable":3,"etf":0,"ttmEps":1.841012,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1786996800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":50.41,"dividendRate":0.004081,"preHourTrading":{"tag":"盘前","latestPrice":49.05,"preClose":50.41,"latestTime":"09:29 EDT","volume":1760,"amount":88101.83008,"timestamp":1786973399999,"change":-1.36,"changeRate":-0.026979,"amplitude":0.089268},"postHourTrading":{"tag":"盘后","latestPrice":50.41,"preClose":50.41,"latestTime":"19:34 EDT","volume":35406,"amount":1784821.54,"timestamp":1786750445375,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.594404,"impliedVol":0.3044,"impliedVolPercentile":0.0478},"requestUrl":"/m/hq/s/CNMD","defaultTab":"news","newsList":[{"id":"1116053961","title":"CONMED Corporation 宣布FDA批准的Airseal®机器人解决方案扩展适应症,适用于Intuitive Da Vinci 5六角套管","url":"https://stock-news.laohu8.com/highlight/detail?id=1116053961","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116053961?lang=zh_cn&edition=full","pubTime":"2026-07-22 19:02","pubTimestamp":1784718135,"startTime":"0","endTime":"0","summary":"CONMED Corporation 宣布,其已获得美国食品药品监督管理局(FDA)批准的Airseal®机器人解决方案,其适应症范围已获扩展,现可配合Intuitive公司的Da Vinci 5六角套管使用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU1815336091.USD","CNMD","LU0053671581.USD","LU0757428866.USD","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140479394","title":"财报前瞻|CONMED Corporation本季度营收预计小幅下滑,机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1140479394","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140479394?lang=zh_cn&edition=full","pubTime":"2026-07-22 16:33","pubTimestamp":1784709215,"startTime":"0","endTime":"0","summary":"CONMED Corporation将于2026年07月29日发布最新季度财报,市场关注利润率与现金流改善节奏及外科器械需求修复路径。多家机构对CONMED Corporation的短期表现持偏谨慎态度,普遍认为本季度营收与盈利小幅下行的概率更高,理由集中在手术量复苏节奏温和与费用刚性导致的利润率压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻|CONMED Corporation本季度营收预计小幅下滑,机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197880973","title":"CONMED公司宣布:John E. Gallagher接任Todd Garner成为新任首席财务官;Garner将留任顾问至2026年11月2日","url":"https://stock-news.laohu8.com/highlight/detail?id=1197880973","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197880973?lang=zh_cn&edition=full","pubTime":"2026-06-18 04:37","pubTimestamp":1781728630,"startTime":"0","endTime":"0","summary":"CONMED公司宣布了其首席财务官职位的重要变动。与此同时,Todd Garner并不会立即离开公司,他将继续以顾问身份留任,为公司的财务事务提供指导,这一顾问角色的任期将持续至2026年11月2日。此次人事变动标志着CONMED公司财务管理团队的一次平稳过渡。这一安排体现了公司治理的前瞻性,既完成了关键岗位的新老交替,又保留了资深高管的智慧,以协助公司应对未来的财务挑战与机遇。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","LU1878469433.USD","LU0757428866.USD","LU1815336091.USD","CNMD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142555290","title":"CONMED公司签订协议 将于6月3日回购2027年到期的2.25%可转换优先票据 - 美国证券交易委员会文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1142555290","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142555290?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:32","pubTimestamp":1780572737,"startTime":"0","endTime":"0","summary":"CONMED公司已签订协议,计划于6月3日回购其2027年到期的2.25%可转换优先票据。此举已在美国证券交易委员会的相关文件中披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0757428866.USD","LU0053671581.USD","BK4082","CNMD","LU1815336091.USD","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152379687","title":"CONMED Corporation于2026年5月27日提交SEC文件:签署首份综合修订协议并提高信贷额度激活通知","url":"https://stock-news.laohu8.com/highlight/detail?id=1152379687","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152379687?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:35","pubTimestamp":1780317307,"startTime":"0","endTime":"0","summary":"CONMED Corporation于2026年5月27日向美国证券交易委员会(SEC)提交了一份文件,披露其已签署了首份综合修订协议,并发布了提高信贷额度激活的通知。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","BK4082","LU0053671581.USD","LU1815336091.USD","CNMD","LU0757428866.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167551238","title":"南微医学收购Conmed三大产品线 内窥镜耗材版图再扩张","url":"https://stock-news.laohu8.com/highlight/detail?id=1167551238","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167551238?lang=zh_cn&edition=full","pubTime":"2026-03-18 22:03","pubTimestamp":1773842601,"startTime":"0","endTime":"0","summary":"南微医学已签署最终协议,收购Conmed Corporation旗下的Duraclip、Precisor及Optibite三条产品线。此次交易标志着南微医学在内窥镜耗材领域的一次重要战略布局,具体交易金额与交割时间等细节尚未披露。南微医学此次收购Conmed部分产品线,符合其通过外部并购强化核心业务竞争力的战略路径。市场关注此次收购对南微医学财务结构及盈利能力的潜在影响。尽管交易对价未公开,但整合Conmed成熟产品线预计将带来即时的收入贡献。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","LU1815336091.USD","LU0053671581.USD","CNMD","BK4082","LU0757428866.USD","688029","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.conmed.com","stockEarnings":[{"period":"1week","weight":0.0263},{"period":"1month","weight":0.1781},{"period":"3month","weight":0.4204},{"period":"6month","weight":0.206},{"period":"1year","weight":-0.0424},{"period":"ytd","weight":0.2416}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0285},{"period":"3month","weight":0.0503},{"period":"6month","weight":0.1387},{"period":"1year","weight":0.2037},{"period":"ytd","weight":0.1385}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CONMED Corporation于1970年根据纽约州法律成立,2020年5月成为特拉华州公司。CONMED是一家以用于微创手术和监测的外科手术器械和设备为重点的医疗技术公司。公司的产品主要被外科医生和各个专科包括骨科,普通外科,妇产科,神经外科,肠胃科的主治医师所使用。公司的主要目标就是通过创新医疗设备的开发,对现有产品的改进以及新技术的开发,以此来提高手术结果的质量和病人的护理,并且能降低风险,创伤,费用以及手术的时间。公司相信,通过满足这些目标,可以提高其预测的能力,适应客户的需求和市场机遇,并且能为股东带来丰厚的投资回报。","yearOnYearQuotes":[{"month":1,"riseRate":0.564103,"avgChangeRate":0.015619},{"month":2,"riseRate":0.641026,"avgChangeRate":0.008939},{"month":3,"riseRate":0.615385,"avgChangeRate":0.008441},{"month":4,"riseRate":0.512821,"avgChangeRate":0.015168},{"month":5,"riseRate":0.564103,"avgChangeRate":0.027258},{"month":6,"riseRate":0.435897,"avgChangeRate":0.003915},{"month":7,"riseRate":0.538462,"avgChangeRate":0.005874},{"month":8,"riseRate":0.5,"avgChangeRate":0.000388},{"month":9,"riseRate":0.487179,"avgChangeRate":0.002307},{"month":10,"riseRate":0.410256,"avgChangeRate":-0.007565},{"month":11,"riseRate":0.589744,"avgChangeRate":0.030081},{"month":12,"riseRate":0.692308,"avgChangeRate":0.051514}],"exchange":"NYSE","name":"CONMED Corporation","nameEN":"Conmed"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CONMED Corporation(CNMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CONMED Corporation(CNMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CONMED Corporation,CNMD,CONMED Corporation股票,CONMED Corporation股票老虎,CONMED Corporation股票老虎国际,CONMED Corporation行情,CONMED Corporation股票行情,CONMED Corporation股价,CONMED Corporation股市,CONMED Corporation股票价格,CONMED Corporation股票交易,CONMED Corporation股票购买,CONMED Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CONMED Corporation(CNMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CONMED Corporation(CNMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}